Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2288)
All Articles published online
|
Jul 7, 2009 (publication date) through May 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Assimakopoulos SF, Thomopoulos KC, Labropoulou-Karatza C. Pentoxifylline: A first line treatment option for severe alcoholic hepatitis and hepatorenal syndrome? World J Gastroenterol 2009; 15(25): 3194-3195 [PMID: 19575503 DOI: 10.3748/wjg.15.3194] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i25/3194.htm |
| Number | Citing Articles |
| 1 |
A A Svistunov, M A Osadchuk, N V Kireeva, M M Osadchuk. Optimizing therapy of liver diseases not associated with viral infection. Terapevticheskii arkhiv 2018; 90(2): 94 doi: 10.26442/terarkh2018902105-111
|
| 2 |
Thomas H. Frazier, Abigail M. Stocker, Nicole A. Kershner, Luis S. Marsano, Craig J. McClain. Treatment of alcoholic liver disease. Therapeutic Advances in Gastroenterology 2011; 4(1): 63 doi: 10.1177/1756283X10378925
|
| 3 |
Rakhi Maiwall, S. K. Sarin, Richard Moreau. Acute kidney injury in acute on chronic liver failure. Hepatology International 2016; 10(2): 245 doi: 10.1007/s12072-015-9652-y
|
| 4 |
Jinsol Han, Chanbin Lee, Jin Hur, Youngmi Jung. Current Therapeutic Options and Potential of Mesenchymal Stem Cell Therapy for Alcoholic Liver Disease. Cells 2022; 12(1): 22 doi: 10.3390/cells12010022
|
| 5 |
Srinivasan Dasarathy, Mack C. Mitchell, Bruce Barton, Craig J. McClain, Gyongyi Szabo, Laura E. Nagy, Svetlana Radaeva, Arthur J. McCullough. Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis. Contemporary Clinical Trials 2020; 96: 106094 doi: 10.1016/j.cct.2020.106094
|
| 6 |
Ki Tae Suk, Soon Koo Baik, Jung Hwan Yoon, Jae Youn Cheong, Yong Han Paik, Chang Hyeong Lee, Young Seok Kim, Jin Woo Lee, Dong Joon Kim, Sung Won Cho, Seong Gyu Hwang, Joo Hyun Sohn, Moon Young Kim, Young Bae Kim, Jae Geun Kim, Yong Kyun Cho, Moon Seok Choi, Hyung Joon Kim, Hyun Woong Lee, Seung Up Kim, Ja Kyung Kim, Jin Young Choi, Dae Won Jun, Won Young Tak, Byung Seok Lee, Byoung Kuk Jang, Woo Jin Chung, Hong Soo Kim, Jae Young Jang, Soung Won Jeong, Sang Gyune Kim, Oh Sang Kwon, Young Kul Jung, Won Hyeok Choe, June Sung Lee, In Hee Kim, Jae Jun Shim, Gab Jin Cheon, Si Hyun Bae, Yeon Seok Seo, Dae Hee Choi, Se Jin Jang. Revision and update on clinical practice guideline for liver cirrhosis. The Korean Journal of Hepatology 2012; 18(1): 1 doi: 10.3350/kjhep.2012.18.1.1
|
| 7 |
T. Sauerbruch, B. Appenrodt. Therapie-Handbuch Grundwerk inkl 6. Lfg.. 2007; : 1 doi: 10.1016/B978-3-437-22107-1.50030-3
|
| 8 |
Vassilios Papastergiou, Andrew K Burroughs, Emmanuel A Tsochatzis. Prognosis and treatment of patients with acute alcoholic hepatitis. Expert Review of Gastroenterology & Hepatology 2014; 8(5): 471 doi: 10.1586/17474124.2014.903800
|
| 9 |
Stefani Vircheva, Albena Alexandrova, Almira Georgieva, Polina Mateeva, Rositza Zamfirova, Marta Kubera, Margarita Kirkova. In vivo effects of pentoxifylline on enzyme and non‐enzyme antioxidant levels in rat liver after carrageenan‐induced paw inflammation. Cell Biochemistry and Function 2010; 28(8): 668 doi: 10.1002/cbf.1705
|
| 10 |
Imran Memon, Christina L Klein. Impact of hepatorenal syndrome and liver transplantation. Current Opinion in Organ Transplantation 2011; 16(3): 301 doi: 10.1097/MOT.0b013e328346576c
|
| 11 |
Therapie–Handbuch Innere Medizin Sonderedition 2011⁄2012. 2011; : 445 doi: 10.1016/B978-3-437-22702-8.50010-8
|
| 12 |
Garmen A. Woo, Christopher O'Brien. Long-term Management of Alcoholic Liver Disease. Clinics in Liver Disease 2012; 16(4): 763 doi: 10.1016/j.cld.2012.08.007
|
| 13 |
David Kershenobich, Dana Lau Corona, Ruben Kershenovich, Gabriela Gutierrez-Reyes. Management of Alcoholic Liver Disease: An Update. Alcoholism: Clinical and Experimental Research 2011; 35(5): 804 doi: 10.1111/j.1530-0277.2010.01402.x
|
| 14 |
Sukhpreet Singh, Natalia A Osna, Kusum K Kharbanda. Treatment options for alcoholic and non-alcoholic fatty liver disease: A review. World Journal of Gastroenterology 2017; 23(36): 6549-6570 doi: 10.3748/wjg.v23.i36.6549
|
| 15 |
Jeffrey D. DellaVolpe, Jeffrey M. Garavaglia, David T. Huang. Management of Complications of End-Stage Liver Disease in the Intensive Care Unit. Journal of Intensive Care Medicine 2016; 31(2): 94 doi: 10.1177/0885066614551144
|
| 16 |
Faryal Tahir, Haris Riaz, Anis Rehman, Muhammad Bilal Munir. Potential role of TNF alpha blockers in delaying the progression of hepato-renal syndrome. Medical Hypotheses 2012; 78(2): 225 doi: 10.1016/j.mehy.2011.10.030
|